{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:45:07Z","timestamp":1771620307742,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/fjc.0b013e3181855cef","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T07:21:46Z","timestamp":1221549706000},"page":"253-261","source":"Crossref","is-referenced-by-count":22,"title":["Effect of L-2286, a Poly(ADP-ribose)polymerase Inhibitor and Enalapril on Myocardial Remodeling and Heart Failure"],"prefix":"10.1097","volume":"52","author":[{"given":"Eva","family":"Bartha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyongyi N","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endre","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u0151z\u0151","family":"Kulcs\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"K\u00e1lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1lm\u00e1n","family":"Hideg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Habon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"Sumegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Halmosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210208","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0008-6363(02)00644-2","article-title":"Beneficial effect of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.","volume":"57","author":"Nakamura","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R2-7-20210208","first-page":"H53","article-title":"Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR protein in heart failure.","volume":"276","author":"Takeishi","year":"1999","journal-title":"Am J Physiol"},{"key":"R3-7-20210208","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with epleronone and ACE inhibition in rats with myocardial infaction.","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R4-7-20210208","doi-asserted-by":"crossref","first-page":"H695","DOI":"10.1152\/ajpheart.00783.2004","article-title":"Regulation of atrial contraction by PKA and PKC during development and regression of eccentric cardiac hypertrophy.","volume":"288","author":"Haddad","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R5-7-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cardiores.2006.03.017","article-title":"Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits.","volume":"71","author":"Li","year":"2006","journal-title":"Cardiovas Res"},{"key":"R6-7-20210208","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/0735-1097(95)00102-A","article-title":"Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing.","volume":"25","author":"Ball","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R7-7-20210208","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(98)01193-6","article-title":"Role of poly(ADP-ribose)synthetase in inflammation and ischaemia-reperfusion.","volume":"19","author":"Szabo","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"R8-7-20210208","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.","volume":"54","author":"Virag","year":"2002","journal-title":"Pharmacol Rev"},{"key":"R9-7-20210208","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cardiores.2003.09.029","article-title":"Poly(ADP-ribose) polymerase activation in the reperfused myocardium.","volume":"61","author":"Szabo","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R10-7-20210208","first-page":"17","article-title":"Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors.","volume":"9","author":"Kovacs","year":"2004","journal-title":"Exp Clin Cardiol"},{"key":"R11-7-20210208","doi-asserted-by":"crossref","first-page":"H1408","DOI":"10.1152\/ajpheart.00953.2003","article-title":"Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1.","volume":"286","author":"Zingarelli","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R12-7-20210208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03402179","article-title":"Absence of poly(ADP-ribose) polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injury.","volume":"9","author":"Zingarelli","year":"2003","journal-title":"Mol Med"},{"key":"R13-7-20210208","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bcp.2005.05.036","article-title":"Critical role of PI3-kinase\/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.","volume":"71","author":"Kovacs","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"R14-7-20210208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy.","volume":"115","author":"Dorn","year":"2005","journal-title":"J Clin Invest"},{"key":"R15-7-20210208","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2006.03.427","article-title":"PARP inhibition prevents postinfarction myocardial remodeling and heart failure via protein kinase C\/glygogen synthase kinase-3 pathway.","volume":"41","author":"Palfi","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R16-7-20210208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.105.088336","article-title":"The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose)polymerase inhibition in Langendorff perfused and in isoproterenol-damaged hearts.","volume":"315","author":"Palfi","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-7-20210208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yjmcc.2006.03.009","article-title":"Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.","volume":"41","author":"Das","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R18-7-20210208","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.HYP.38.3.404","article-title":"Differential subcellular actions of ACE inhibitors and AT receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.","volume":"38","author":"Sanada","year":"2001","journal-title":"Hypertension"},{"key":"R19-7-20210208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.75.1.105","article-title":"Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats.","volume":"75","author":"Teerlink","year":"1994","journal-title":"Circ Res"},{"key":"R20-7-20210208","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.92.9.2666","article-title":"Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoreceptor responses in rats with chronic heart failure.","volume":"92","author":"Sanbe","year":"1995","journal-title":"Circulation"},{"key":"R21-7-20210208","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0022-2828(95)91551-6","article-title":"Effects of long-term therapy with ACE inhibitors, captopril, enalapril, trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.","volume":"27","author":"Sanbe","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"R23-7-20210208","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1291\/hypres.26.421","article-title":"Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl Salt-Sensitive rats.","volume":"26","author":"Koide","year":"2003","journal-title":"Hypertens Res"},{"key":"R24-7-20210208","doi-asserted-by":"crossref","first-page":"35767","DOI":"10.1074\/jbc.M507075200","article-title":"Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.","volume":"280","author":"Tapodi","year":"2005","journal-title":"J Biol Chem"},{"key":"R25-7-20210208","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1124\/mol.59.6.1497","article-title":"Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.","volume":"59","author":"Halmosi","year":"2001","journal-title":"Mol Pharmacol"},{"key":"R26-7-20210208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2119\/2006-00043.Molnar","article-title":"Activation of the poly(ADP-ribose)polymerase pathway in human heart failure.","volume":"12","author":"Molnar","year":"2006","journal-title":"Mol Med"},{"key":"R27-7-20210208","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","article-title":"MEK1-ERK2 Signaling pathway protects myocardium from ischemic injury in vivo.","volume":"109","author":"Lips","year":"2004","journal-title":"Circulation"},{"key":"R28-7-20210208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","article-title":"Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.","volume":"37","author":"Grimm","year":"1998","journal-title":"Cardiovasc Res"},{"key":"R29-7-20210208","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cardiores.2005.09.011","article-title":"Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease.","volume":"69","author":"Penela","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R30-7-20210208","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachy-pacing-induced congestive heart failure.","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"R31-7-20210208","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2004.07.038","article-title":"p38 Mitogen-Activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.","volume":"44","author":"See","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R32-7-20210208","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardiores.2005.11.015","article-title":"Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster.","volume":"69","author":"Kyoi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R33-7-20210208","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbadis.2004.11.007","article-title":"Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits.","volume":"1740","author":"Qin","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"R34-7-20210208","doi-asserted-by":"crossref","first-page":"32288","DOI":"10.1074\/jbc.M704001200","article-title":"A protein kinase Cepsilon\/anti-apoptotic kinase signalling complex protects human vascular endothelial cell against apoptosis through induction of Bcl-2.","volume":"282","author":"Steinberg","year":"2007","journal-title":"J Biol Chem"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0b013e3181855cef","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:17:55Z","timestamp":1620951475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-200809000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181855cef","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}